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It is not known whether changing from isoﬂurane to desﬂurane during the latter part of anesthesia 
shows early emergence and recovery in long surgery.  We therefore evaluated the eﬀects of changing 
isoﬂurane to desﬂurane on emergence and recovery.  Eighty-two patients were randomly assigned to 
receive isoﬂurane (Group I) or desﬂurane (Group D) or to change from isoﬂurane to desﬂurane anes-
thesia (Group X).  At the point when there was an hour until the operation would end,  isoﬂurane was 
replaced with 1 MAC of desﬂurane in Group X,  and isoﬂurane and desﬂurane were maintained at 1 
MAC in Groups I and D.  When the operation ended,  we compared the emergence and recovery char-
acteristics among the 3 groups.  Compared with Group I,  Group X showed faster emergence and 
recovery.  Group X and Group D showed similar emergence and recovery.  In conclusion,  changing 
isoﬂurane to desﬂurane during the latter part of anesthesia improves emergence and recovery.
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ecovery from anesthesia is inﬂuenced by the 
choice of anesthetic agent.  The new inhaled 
anesthetics have markedly improved the quality and the 
time required for recovery compared with older anes-
thetics.  Desﬂurane,  in particular,  is a new inhaled 
anesthetic agent with a very low blood-gas partition 
coeﬃcient,  which allows for rapid emergence and 
recovery at the end of surgery [1-4].  However,  des-
ﬂurane is more expensive to administer than other 
inhalational anesthetics [5].
　 Isoﬂurane is a commonly used inhaled volatile 
anesthetic agent because it is relatively inexpensive 
despite its high solubility [6].  Attempts to combine 
the advantages of rapid emergence from desﬂurane 
with the lower cost of the more soluble isoﬂurane have 
proved to be ineﬀective [7,  8].  However,  these stud-
ies were carried out with a small sample size and 
outside of clinical situations including volunteers and 
rats.  In addition,  the duration of anesthesia and the 
cross-over time were short.  In addition,  the authors 
have previously reported that changing from enﬂurane 
to desﬂurane during the latter part of anesthesia 
improves emergence and recovery in a long operation 
[9].
　 We hypothesized that in clinical situations having a 
longer duration of anesthesia and cross-over time,  
changing from isoﬂurane to desﬂurane anesthesia 
improves emergence and recovery.  We therefore 
designed a double-blind prospective randomized study 
R
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to test the hypothesis that when anesthetized patients 
undergo a laparotomy lasting 3 or more hours,  chang-
ing from isoﬂurane to desﬂurane result in earlier 
emergence and recovery than pure isoﬂurane anesthe-
sia and nearly equal emergence and recovery charac-
teristics with pure desﬂurane anesthesia.
Materials and Methods
　 The study was approved by the Institutional 
Review Board at the Chung-Ang University College of 
Medicine and was registered with ANZCTR 
(ACTRN12610000013066).  This study was carried 
out according to the principles of the Declaration of 
Helsinki,  2000,  and written informed consent was 
obtained from all the participants.
　 Patients and groups. All patients undergoing 
laparotomy expected to last for 3 or more hours under 
general anesthesia at Chung-Ang University Hospital,  
Department of Surgery,  who were between 18 and 65 
years of age were candidate for inclusion in this study.  
The operations included in this study were total gast-
rectomy,  subtotal gastrectomy,  liver lobectomy,  liver 
segmentectomy,  colectomy,  hemicolectomy,  and 
Whippleʼs operation.  Patients with clinically signiﬁ-
cant pulmonary,  cardiovascular,  hepatic,  renal,  
hematologic,  neurologic,  or metabolic diseases and 
those who were chronic users of drugs that are known 
to aﬀect anesthetic requirements were excluded from 
the study.
　 The patients were randomly assigned,  using Excel 
random number generation,  into 3 groups: an isoﬂu-
rane group (Group I),  a desﬂurane group (Group D),  
or a changing from isoﬂurane to desﬂurane group 
(Group X).  Allocation concealment was achieved by 
placing the randomization sequence for each subject in 
sequentially numbered sealed brown envelopes.  After 
admission to the operating room,  and just before 
induction of anesthesia,  the appropriate numbered 
envelope was opened and the card inside told if the 
patient was to be in Group I,  Group D,  or Group X.
　 General anesthesia. All patients were trans-
ferred to the operating room without premedication.  
Anesthesia was induced with 4-5mg/kg thiopental,  
0.1mg/kg vecuronium,  and 2µg/kg fentanyl.  Standard 
monitoring (including electrocardiography,  heart rate,  
pulse oximetry,  noninvasive blood pressure) and state 
entropy (SE) were monitored throughout the opera-
tion.  After tracheal intubation,  anesthesia was main-
tained with 1.2-2.4 volｵ isoﬂurane or 6-12 volｵ 
desﬂurane (end-tidal concentration) in 1.5l/min 
nitrous oxide (N2O),  and 1.5l/min O2,  depending on 
the vital signs and SE.  Ventilation was controlled,  
and the end-tidal carbon dioxide tension (PET CO2) was 
maintained within the range of 32-38mmHg.  
Neuromuscular block was monitored with a peripheral 
nerve stimulator,  and additional increments of vecuro-
nium were administered if the train-of-four count was 
more than one twitch.  The concentrations of isoﬂu-
rane,  desﬂurane,  N2O,  and CO2 were measured con-
tinuously using an anesthetic gas monitoring system 
(S/5TM Compact anesthesia monitor; Datex-Ohmeda,  
Tewksbury,  MA,  USA).  The lower limits of sensitiv-
ity for isoﬂurane and desﬂurane were 0.01ｵ and 0.1ｵ,  
respectively.
　 To control postoperative pain,  intravenous patient-
controlled analgesia (PCA,  Automed 3300TM,  
AceMedical Co.,  Seoul,  S.  Korea) was used to 
administer fentanyl.  The mode of PCA was a continu-
ous infusion of 0.125µg/kg/h with boluses of 
0.125µg/kg and a lockout interval of 15 min (total 
regimen 100ml).
　 At the point when the operation was predicted to 
end in an hour,  the isoﬂurane dose was reduced to 1 
minimum alveolar concentration (MAC,  1.2ｵ end-
tidal concentration in isoﬂurane) in Group I,  the des-
ﬂurane dose was reduced to 1 MAC (6ｵ end-tidal 
concentration in desﬂurane) in Group D,  or the isoﬂu-
rane was replaced with 1 MAC of desﬂurane in Group 
X [6].  Spontaneous ventilation was established 
before starting skin closure.  Isoﬂurane or desﬂurane 
and N2O were discontinued immediately after the skin 
closure.  The patientsʼ lungs were then ventilated with 
100ｵ O2 at a total gas ﬂow rate of 5l/min.  Patientsʼ 
breathing was maintained under assisted ventilation 
before discontinuation of inhalation anesthetics,  and 
under spontaneous ventilation after discontinuation of 
inhalation anesthetics.  The patientsʼ tracheae were 
extubated after the reversal of neuromuscular block-
ade with a combination of 10-15mg pyridostigmine 
and 0.2-0.4mg glycopyrrolate.  After extubation 
patients were transferred to the PACU and a blinded 
investigator recorded the recovery variables.  At 
PACU,  if the patients expressed prolonged pain of 
over 30mm on the VAS,  they were given an intrave-
nous injection of 50µg fentanyl as rescue analgesia 
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until the pain was relieved (VAS＜30mm).
　 Recovery proﬁle. After discontinuation of the 
inhalation anesthetic,  the time required for the end-
tidal concentration of the volatile anesthetic to reach 
50ｵ of the concentration at its termination was 
recorded.  The response time to painful pinching and 
verbal command,  and to regain orientation to age and 
name were assessed in a uniform manner at 1 min 
intervals after inhalation anesthetic was discontinued.
　Patients were asked to complete the following psy-
chometric tests in the day before surgery and then 30 
and 60 min after discontinuation of anesthetics: 1) a 
digit symbol substitution test (DSST: in which 
patients are asked to match numbers and symbols dur-
ing a 90-s period to measure cognitive ability)[10]: 2) 
a serial 7 test (SST: in which patients are asked to 
subtract 7 continuously from 100 and the time to 
reach the last number is measured)[11].  Patients 
were discharged from PACU according to our local 
score,  derived from the Aldrete score [12].  
　 The primary outcome measure of this study was the 
response time to appropriate verbal command.  
Secondary outcome measures included: the response 
time to painful pinching,  regaining orientation to age 
and name,  time to ﬁtness for discharge from PACU,  
DSST and SST.
　 Consumption of inhalation anesthetics was calcu-
lated using the equation presented by Weiskpof and 
Eger,  [5] and the costs of consumed inhalation anes-
thetic were calculated based on our hospital pharmacy 
list.  The exchange rate from the Korean won to the 
United States dollar was 1 dollar＝1103.20 won.  
　 Statistical analysis. To calculate the required 
sample size for the study,  the diﬀerence in recovery 
times between isoﬂurane and desﬂurane anesthesia 
reported in a similar clinical setting was considered 
[1].  We accepted a two-tailed α error of 5ｵ and a β 
error of 10ｵ to detect a 2-min diﬀerence among the 3 
groups with regard to the time taken to open eyes in 
response to the appropriate verbal command.  Based 
on these calculations,  the required sample size for the 
study was 26 per group.  To compensate for a patient 
refusal rate of 20ｵ and a dropout rate of 5ｵ,  we 
asked 103 patients to participate in the study.
　 For intergroup comparisons,  ANOVA with the 
Tukey post hoc test was used to compare the continu-
ous variables in the three treatment groups.  The 
shifts from the baseline values and systematic diﬀer-
ences in the hemodynamic variables,  inhalation con-
centration,  PETCO2,  and psychometric test results 
were analyzed between the 3 groups by a repeated 
measures analysis of variance (ANOVA) followed by a 
simple contrast.  The descriptive variables were ana-
lyzed by either by chi-square analysis or Fisherʼs 
exact test,  as appropriate.  P values of＜0.05 were 
considered statistically signiﬁcant.  
　 In the Table,  data are presented as mean±stan-
dard deviation if normally distributed,  and if not as 
median (interquartile range) or absolute values.  In the 
Figure,  data are presented mean values with vari-
ability expressed as standard error.  Statistical analy-
sis was performed with SPSS version 15.0 (SPSS,  
USA).  
Results
　 Among the 103 patients who were asked to partici-
pate in the study between Sep 2008 and Oct 2009,  13 
patients refused to participate and 8 patients were 
excluded as they suﬀered from cardiac,  pulmonary,  
renal,  or neurologic disease or were chronic users of 
drugs,  both of which are known to aﬀect anesthetic 
requirements.  Of the 82 patients,  27 were random-
ized to Group I,  29 to Group D,  and 26 to Group X.
　 As shown in Table 1,  there were no signiﬁcant 
diﬀerences in the demographic data.  The duration of 
anesthesia,  operation,  and cross-over period and the 
number of patients who required medication intraop-
eratively and postoperatively did not diﬀer (Table 2).  
Hemodynamic variables in the 3 groups did not diﬀer 
before the reduction or change in the inhalation anes-
thetic (baseline),  and there were no systematic diﬀer-
ences after reductions or changes in the anesthetics 
(Figs.  1A,  1B).
　 MAC did not diﬀer systematically among groups,  
and did not diﬀer from baseline at any time in Group 
I and Group D: however MAC was signiﬁcantly higher 
than baseline from 5 min to 10 min in Group X (p＜
0.05,  Fig.  2A).  MAC of desﬂurane and isoﬂurane,  
and the sum of MAC in Group X are presented in Fig.  
2B.  SE was signiﬁcantly lower than the baseline from 
5 min to 20 min in Group X (p＜0.05),  but did not 
diﬀer from baseline at any time in Group I and Group 
D (Fig.  3).
　 The patients in Group D responded to painful 
pinching,  opened their eyes to the appropriate verbal 
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command,  regained orientation to name and reached 
the ﬁtness for discharge from PACU earlier than 
those in Group I (p＜0.05) and the patients in Group 
X responded to verbal command and reached the ﬁt-
ness for discharge from PACU earlier than those in 
Group I (p＜0.05),  but there were no diﬀerence 
between Group X and Group D (Table 3).  After dis-
continuation of volatile anesthetic,  the time required 
for the end-tidal concentration of the volatile anes-
thetic to reach 50ｵ of its termination value was sig-
niﬁcantly less in Group X and Group D than in Group 
I (p＜0.001),  but there were no signiﬁcant diﬀer-
ences between Group I and Group D (Table 3).
　 Five patients in Group I,  3 in Group X,  and 3 in 
Group D at 30 min and 2 patients in Group I,  2 in 
Group X,  and 2 in Group D at 60 min could not per-
form DSST and SST because of severe pain.  In 
addition,  5 patients in Group I,  2 in Group X,  and 2 
in Group D at 30 min and 6 patients in Group I,  1 in 
Group X,  and 1 in Group D at 60 min could not per-
form DSST and SST because they sleep without 
interruption.  Patients who could not perform DSST 
and SST were excluded from the analysis.  There 
were no diﬀerences in the DSST and SST before the 
surgery; patients performed signiﬁcantly better in 
Group X and Group D than Group I at 30 and 60 min 
after admission to the PACU (p＜0.05).  However,  
the DSST and SST scores at 30 and 60 min diﬀered 
signiﬁcantly from before the surgery (p＜0.05,  Table 
4).  
　 The cost of consumed inhalation anesthetics was 
higher in Group D than in Group X and Group C (p
＜0.05),  and higher in Group X than in Group C (p
＜0.05,  Table 5).
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Table 1　 Demographic data and times
Group I
(n＝27)
Group X
(n＝26)
Group D
(n＝29)
Age; years 61.0(58.0-68.0[18-65])
59.5
(48.8-66.5[18-65])
64.0
(53.5-72.5[18-65])
Gender M 17 (63.0) 16 (61.5) 15 (51.7)
　　　 F 10 (37.0) 10 (38.5) 14 (48.3)
Height; cm 166.1(6.9) 165.4 (7.3) 161.6 (7.9)
Weight; kg 63.9 (8.7) 63.5 (8.3) 61.0 (6.8)
ASA　　Ⅰ 14 (51.9) 14 (53.8) 14 (48.3)
　　　   Ⅱ 11 (40.7) 11 (42.4) 14 (48.3)
　　　   Ⅲ 2 (7.4) 1 (3.8) 1 (3.4)
Cross-over time; min 67.2 (13.5) 62.5 (12.6) 63.0 (11.2)
Op time; min 224.9 (83.7) 220.4 (75.8) 250.7 (76.7)
Ane time; min 246.4 (82.6) 237.2 (71.4) 275.8 (88.7)
Values are median (IQR[Range]),  mean (SD),  and number (proportion).  No signiﬁcant diﬀerences among groups.  ASA,  American Society 
of Anesthesiologists physical status; Op, operation; Ane,  anesthesia.
Table 2　 Additional drug requirement
Group I
(n＝27)
Group X
(n＝26)
Group D
(n＝29) P-value
Intra OP
　Glycopyrrolate 2 (7.4) 3 (11.5) 2 (6.9) 0.801†
　Ephedrine 2 (7.4) 2 (7.6) 2 (6.9) 0.993†
　Fentanyl 10 (37.0) 10 (38.5) 12 (41.4) 0.944
　Vecuronium (mg) 14.9 (2.3) 14.8 (2.6) 14.6 (2.2) 0.914
Post OP
　Fentanyl 8 (29.6) 9 (34.6) 11 (37.9) 0.806
　Ondansetron 9 (33.3) 7 (26.9) 9 (31.0) 0.877
Values are mean (SD),  and number (proportion).  No signiﬁcant diﬀerences among groups.  OP,  operation.  † Fisherʼs exact test was used.
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Fig. 1　 A,  Changes in mean arterial pressure during the cross-over period.  Each line represents mean±SE; B,  Changes in heart rate 
during the cross-over period.  Each line represents mean±SE.  0,  beginning of cross-over; End,  end of operation.
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Fig. 2　 A,  End-tidal MAC of inhalation agent during the cross-over period.  Group X represents the sum of MAC in isoﬂurane and desﬂu-
rane.  Each line represents the mean±SE.  ＊P＜0.05 within group in comparison with baseline value; B,  End-tidal MAC of inhalation 
agent during the cross-over period in Group X.  0,  beginning of cross-over; End,  end of operation.
Discussion
　 Our ﬁndings support the hypothesis that when 
anesthetized patients undergo laparotomy lasting 3 or 
more hours,  changing from isoﬂurane to desﬂurane 
anesthesia results in earlier emergence and recovery 
than pure isoﬂurane anesthesia,  and nearly equal 
emergence and recovery with desﬂurane anesthesia.  In 
agreement with other studies [1,  13],  we also found 
that emergence and recovery after desﬂurane is more 
rapid than that after the more soluble isoﬂurane.
　 As a primary outcome measure,  the time to open 
eyes to the appropriate verbal command was earlier in 
Group X and Group D than in Group I.  Additionally,  
Group X and Group D performed better postopera-
tively in both the SST and DSST than Group I.  
Considering that more patients cannot perform DSST 
and SST postoperatively,  these diﬀerences may be 
potentiated.  These diﬀerences in emergence and 
recovery proﬁles were not caused by diﬀerences in the 
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Fig. 3　 State entropy during the cross-over period.  Each line represents the mean±SE.  ＊P＜0.05 within group in comparison with 
baseline value.  0,  beginning of cross-over; End,  end of operation.
Table 3　 Emergence and recovery characteristics
Group I
(n＝27)
Group X
(n＝26)
Group D
(n＝29) P-value
T 50％ dec; sec 100(80-150[45-180])
50
(43-57.3[35-120])＊
60
(55-70[45-110])＊ ＜0.001
Painful pinch; min 25.2 (13.0) 20.5 (10.7) 19.1 (8.9)＊ 0.036
Verbal command; min 29.4 (7.6) 22.9 (11.6)＊ 20.3 (9.3)＊ 0.002
Age; min 36.1 (9.7) 29.2 (13.9) 28.1 (13.0) 0.039
Name; min 35.6 (9.1) 29.0 (13.8) 28.0 (12.6)＊ 0.046
PACU discharge; min 47.2 (9.3) 39.4 (12.5)＊ 37.3 (10.8)＊ 0.003
Values are median (IQR[Range]), mean (SD), number (proportion).  ＊P＜0.05 compared with group I,  There were no diﬀerences between 
group X and group D.  T 50％, the time required for the end-tidal concentration of the volatile anesthetic to reach 50％ of the concentration 
at its termination, PACU,  Post Anesthetic Care Unit.
duration of anesthesia,  cross-over period,  or dose of 
used muscle relaxant and opioid,  since none of these 
parameters were signiﬁcantly diﬀerent.  They were 
also not caused by diﬀerences in anesthetic concentra-
tions (MAC) or alveolar ventilation during recovery,  
which was assessed by the end-tidal concentrations of 
anesthetics and CO2: these parameters also did not 
diﬀer among groups.  The pharmacokinetic data rein-
force these clinical results.  The time required for the 
end-tidal concentration of the volatile anesthetic to 
reach 50ｵ of its termination value was signiﬁcantly 
less with desﬂurane and with changing from isoﬂurane 
to desﬂurane anesthesia than with pure isoﬂurane 
anesthesia.  It is somewhat predictable that desﬂurane 
with a blood/gas partition coeﬃcient of 0.42,  com-
pared with 1.4 in isoﬂurane,  washed out at a much 
faster rate resulting in faster emergence and recovery 
[4,  14].  The times to respond to painful pinch and to 
regain orientation to age and name were not signiﬁ-
cantly diﬀerent between Group X and Group I (Table 
3).  The reason for this lack of diﬀerence may be that 
these parameters were not the primary criterion.  As 
we made the reliable group number by calculating the 
time taken to open eyes in response to the appropriate 
verbal command,  the number of patients in the current 
study might be small to provide statistically signiﬁcant 
results for these emergence and recovery parameters.
　 These results are in close agreement with those of 
our previous study,  which showed that changing from 
enﬂurane to desﬂurane results in an earlier emergence 
and recovery proﬁle compared with pure enﬂurane 
anesthesia,  although diﬀerent anesthetics and proto-
cols were used [9].  However,  our ﬁndings are diﬀer-
ent from those of Neumann et al.  [7],  who compared 
the recovery after desﬂurane anesthesia,  isoﬂurane 
anesthesia,  and changing from isoﬂurane to desﬂurane 
anesthesia in 5 volunteers.  Changing from isoﬂurane 
to desﬂurane in their study produced similar results 
with regard to the response times to a command,  ori-
entation,  and cognitive performance,  as those 
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Table 4　 Psychometric test
Group I
(n＝27)
Group X
(n＝26)
Group D
(n＝29) P-value
DSST-O  44.04±5.57 43.50±5.01 43.34±4.46 0.866
DSST-30  19.12±9.5† 28.14±10.00＊† 28.54±8.80＊† 0.004
DSST-60  32.76±7.01† 40.57±6.95＊† 40.35±5.74＊† 0.003
SST-0  64.37±11.30 63.58±12.06 64.59±11.53 0.945
SST-30 123.94±31.29† 99.76±35.46＊† 91.79±25.31＊† 0.006
SST-60  84.00±18.94† 70.48±12.91＊† 71.81±9.20＊† 0.003
Values are mean (SD).  Number of patients is 17,  21,  24 at 30 min,  21,  23,  26,  at 60 min in Group I,  Group X,  and Group D respec-
tively.  ＊P＜0.05 compared with group I,  There were no diﬀerences between group X and group D.  †P＜0.05 compared with before sur-
gery.  DSST,  digit symbol substitution test; SST,  Serial 7 test.  -O,  -30,  -60; performed before surgery,  30,  and 60 min postoperatively.
Table 5　 Comparison of costs
Group I
(n＝27)
Group X
(n＝26)
Group D
(n＝29) P-value
Volume of anesthetic used
　Isoﬂurane 74.3 (10.4) 68.8 (9.0)
　Desﬂurane 66.4 (3.1) 269.0 (13.2)
Cost of anesthetic
　Isoﬂurane 46.8 (6.6) 43.2 (5.7)
　Desﬂurane 43.3 (10.5) 175.6 (46.5)
　Sum 46.8 (6.6) 86.7 (14.4)＊ 175.6 (46.5)＊† ＜0.0001
Values are mean (SD).  Costs were calculated based on our institutionʼs pharmacy list (Isoﬂurane 250ml＝157.40 United States Dollar,  
desﬂurane 240ml＝156.7 United States Dollar) and are expressed in United States dollars.  ＊P＜0.05 compared with group I, †P＜0.05 
between group X and group D.
observed with isoﬂurane alone.  We postulate that 
these diﬀerences between the 2 studies result from the 
diﬀerence in the duration of anesthesia(2 h vs.  3 h),  
duration of the cross-over period (30 min vs.  1 h),  
study subjects (5 volunteers vs.  82 patients),  and rate 
of fresh gas ﬂow (2l/min vs.  3l/min).  
　 The time to ﬁtness for discharge from PACU was 
earlier in Group X and Group D than in  Group I.  
Although the clinical signiﬁcance of less than 5 min in 
the time to readiness to leave PACU between Group 
X and Group I may be questioned,  even small diﬀer-
ences in times to leave PACU,  we assume,  may 
translate into signiﬁcant cost- and labor-savings in a 
busy PACU[15,  16].  However,  a more detailed cost-
beneﬁt analysis may be needed to conﬁrm this assump-
tion.
　 In the semi-closed system commonly used,  changing 
isoﬂurane to desﬂurane will not cause the rapid elimi-
nation of isoﬂurane from the circuit and will cause 
rebreathing of isoﬂurane exhaled by the patients.  A 
delayed elimination of isoﬂurane will result.  In addi-
tion,  because desﬂurane is less soluble,  the circuit and 
alveolar concentrations of desﬂurane will increase 
more rapidly than the concentrations of isoﬂurane will 
decrease.  Therefore,  the sum of MAC for each anes-
thetic in Group X increased signiﬁcantly at 5,  10 min 
after cross-over started (Fig.  2A,  2B),  which is 
reﬂected in the lower SE than baseline value from 5 
min to 20 min after the start of the cross-over (Fig.  
3).  Although the decrease in SE lasted longer than the 
duration of the increase in MAC,  we assume that 
these diﬀerences may be caused by end-tidal concen-
trations of isoﬂurane during the cross-over,  which 
were maintained below the lower limits of sensitivity,  
or that the interaction between the 2 anesthetics 
impeded their detection by infra-red gas analyzer.  We 
assume that diﬀerent results may arise if gas chroma-
tography is used.  The possibility that temperature,  
N2O,  and pH may aﬀect this inconsistency also cannot 
be ruled out.
　 Rapid emergence may improve airway protection 
after tracheal extubation in the PACU,  and early 
recovery (such as response to external stimulus,  ori-
entation to age and name) can protect patients from 
accident often less supervised at this time and improve 
postoperative management and cost- and labor-savings 
in a busy PACU.  To achieve such advantages in early 
emergence and recovery,  desﬂurane is most suitable 
for maintaining anesthesia.  However,  desﬂurane is 
more expensive than isoﬂurane,  because its cost is 
relatively high and its high MAC causes a consump-
tion of desﬂurane.  In this study,  the cost of consumed 
inhalation anesthetics was lower in Group X than in 
Group D,  and emergence and recovery were earlier in 
Group X than in Group I.  Thus,  we can achieve twin 
goals of economy and rapid recovery using the sequen-
tial technique (isoﬂurane to desﬂurane).  Further,  
quicker recovery of cognitive function and earlier 
discharge from the PACU to a normal ward may 
reduce staﬀ costs [15,  16].
　 The main disadvantages of changing from isoﬂurane 
to desﬂurane anesthesia are the activation of the 
sympathetic nervous system caused by rapid increases 
in inspired desﬂurane concentrations,  and increases in 
the depth of anesthesia caused by disagreements in 
rate between the elimination of isoﬂurane and the 
uptake of desﬂurane.  In group X,  MAP and HR 
increased at 5 min after the change of anesthetics 
(Fig.  1A,  1B),  which may have been caused by acti-
vation of the sympathetic nervous system [17].  
However this increase did not reach statistical signiﬁ-
cance,  possibly because the residual isoﬂurane oﬀset 
the sympathetic nervous system activation caused by 
desﬂurane.  Increase in the depth of anesthesia was 
reﬂected in an increase in MAC from 5 min to 10 min,  
and a decrease in SE from 5 min to 20 min (Fig.  3).  
This discrepancy in time between increase in MAC and 
decrease in SE may possibly deliver more anesthetic 
than necessary to achieve adequate anesthesia.  
Accordingly,  it may reduce the beneﬁt from the 
decreased cost of consumed anesthetics.
　 The present study does have some limitations.  
First,  to standardize the anesthetic for this study,  
the volatile agent was maintained at 1 MAC until the 
end of surgery.  Most anesthetists do not practice in 
this fashion.  Instead,  they decrease the fraction of 
inhaled anesthetic agent as the anticipated end of 
surgery approaches.  This approach might compensate 
for an expected diﬀerence between isoﬂurane and 
crossover from isoﬂurane to desﬂurane in daily prac-
tice.
　 Second,  despite the rigid protocol,  there remain a 
large number of confounding factors that introduce 
potential errors into the observation.  These include 
diﬀerent operation,  surgeons,  and patient character-
istics.  It is diﬃcult to account for all these confound-
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ing factors and our protocol was designed to minimize 
them as much as possible.  Third,  the observers in the 
operating room were not blinded.  This could have 
added bias to the results,  accentuating or diminishing 
diﬀerences among the three groups.  Finally,  a fresh 
gas ﬂow of 3l/min leads to greater anesthetic con-
sumption compared with a low-ﬂow system.  This 
increased consumption would increase costs and 
decrease the economic beneﬁt from changing anesthet-
ics.  However,  the total cost of anesthetic used when 
changing from isoﬂurane to desﬂurane may be lesser 
than pure desﬂurane anesthesia.
　 In conclusion,  we found that changing anesthetics 
from isoﬂurane to desﬂurane during the last 1 h of 
anesthesia during laparotomy that lasted for 3 h or 
longer improved emergence and recovery.
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